Healthcare & Life Sciences
Immunitas Therapeutics
United Statesimmunitastherapeutics.com
Immunitas Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2
Investors
About Immunitas Therapeutics
Immunitas Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Immunitas Therapeutics uses a single cell genomics platform to analyze immune cell biology within human tumors, enabling identification of novel therapeutic targets and development of biomarkers to guide patient-specific cancer therapies.
Explore Immunitas Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.